Category: Immunai

Israeli company imperviousThe company, which develops artificial intelligence-based tools to improve drug discovery processes, has announced a strategic agreement with pharmaceutical company AstraZeneca. Immunai will receive $18 million from AstraZeneca in the initial phase of research, but the main importance of the deal is not the initial amount, but the…